Commentary

Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

Ampudia-Blasco FJ, Romera I, Ariño B, Gomis R

International Journal of General Medicine 2017, 10:23-26

Published Date: 13 January 2017